|
Medier: |
Investorer: |
|
|
|
|
Mike Rulis |
Peter Haahr |
|
Tlf. (direkte): 4442 3573 |
Tlf. (direkte): 4442 1207 |
|
|
|
|
|
Palle Holm Olesen |
|
|
Tlf. (direkte): 4442 6175 |
Fondsbørsmeddelelse nr. 17 ( 2004)
| Source: Novo Nordisk A/S
|
Medier: |
Investorer: |
|
|
|
|
Mike Rulis |
Peter Haahr |
|
Tlf. (direkte): 4442 3573 |
Tlf. (direkte): 4442 1207 |
|
|
|
|
|
Palle Holm Olesen |
|
|
Tlf. (direkte): 4442 6175 |
Bagsværd, Denmark, 31 August 2026 – On 6 May 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of...
Read MoreBagsværd, Denmark, 24 August 2026 – On 6 May 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of...
Read More